COVID-19 Immunity Task Force
The COVID-19 Immunity Task Force (CITF) was launched to track the spread of the virus in both the general population and priority populations in Canada.
The objectives are to catalyse, support, and, where appropriate and feasible, harmonize the design and rapid implementation of population-based studies. These studies will generate reliable first estimates of SARS-CoV-2 immunity in Canada. The Task Force will also support laboratory studies to establish the advantages and limitations of immunity testing and related technologies, and will generate practical insights into the optimum ways of using and interpreting these tests.
The COVID-19 Immunity Task Force was established in April 2020 and funded by the Government of Canada. Multiple universities, hospitals, and public health experts participate in the initiative.
Overview
- Acronym
- CITF
- Website
- CITF Website
- Investigators
-
- Contacts
-
Harmonization Initiatives
| Acronym | Name | Variables |
|---|
Summary Statistics
Individual Studies
| Acronym | Name | Study design | Countries | Variables |
|---|
Participating Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics 75
- Death 13
- Lifestyle and behaviours 54
- Physical measures and assessments 48
- Birth, pregnancy and reproductive health history 17
- Laboratory measures 63
- Perception of health, quality of life, development and functional limitations 38
- Cognition, personality and psychological measures and assessments 24
- Diseases 71
- Life events, life plans, beliefs and values 23
- Symptoms and signs 59
- Preschool, school and work life 24
- Medication and supplements 69
- Social environment and relationships 32
- Non-pharmacological interventions 65
- Physical environment 43
- Health and community care services utilization 55
- Administrative information 72